BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,567,000 | +16.3% | 647,671 | 0.0% | 0.00% | – |
| Q1 2018 | $1,347,000 | -35.4% | 647,671 | -19.8% | 0.00% | – |
| Q4 2017 | $2,084,000 | +37.6% | 807,770 | -24.3% | 0.00% | – |
| Q3 2017 | $1,515,000 | +2.0% | 1,066,970 | -3.7% | 0.00% | – |
| Q2 2017 | $1,485,000 | -12.8% | 1,108,470 | -3.0% | 0.00% | – |
| Q1 2017 | $1,703,000 | +169.0% | 1,142,970 | -5.4% | 0.00% | – |
| Q4 2016 | $633,000 | -62.6% | 1,208,070 | 0.0% | 0.00% | – |
| Q3 2016 | $1,691,000 | -19.1% | 1,208,070 | 0.0% | 0.00% | – |
| Q2 2016 | $2,090,000 | -33.0% | 1,208,070 | -4.7% | 0.00% | – |
| Q1 2016 | $3,119,000 | -19.1% | 1,267,981 | -2.6% | 0.00% | -100.0% |
| Q4 2015 | $3,854,000 | -43.0% | 1,302,070 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,758,000 | -34.5% | 1,302,070 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $10,325,000 | -13.6% | 1,302,070 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $11,953,000 | – | 1,302,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLINSKY STEVEN B | 4,859,885 | $44,614,000 | 20.33% |
| Senator Investment Group LP | 448,679 | $4,119,000 | 0.04% |
| HIGHLAND CAPITAL MANAGEMENT LP | 162,177 | $1,489,000 | 0.03% |
| Baker Brothers Advisors | 350,000 | $3,213,000 | 0.03% |
| Alyeska Investment Group, L.P. | 94,131 | $864,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,000 | $275,000 | 0.01% |
| FMR LLC | 1,302,070 | $11,953,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,427 | $142,000 | 0.00% |
| BlackRock Investment Management, LLC | 846 | $8,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,290 | $159,000 | 0.00% |